Please enable JS

ARTICLES & TESTIMONIALS

Virginia 1115 Medicaid Waiver

Jul 08/50SN Staff/ Open Comments

January 4, 2019 The Honorable Alex AzarSecretaryU.S. Department of Health and Human Services200 Independence Avenue, SWWashington, DC 20201Re: Virginia COMPASS 1115 Demonstration Extension Application –Creating Opportunities for Medicaid Participants to Achieve Self-SufficiencyDear Secretary Azar: Thank you for the opportunity to submit comments onVirginia’s Section 1115 Demonstration Extension Application. The undersigned organizations represent millions of individuals […]

READ MORE

Amgen Just Slashed Its Price of the Cholesterol-Lowering Drug Repatha. So What Does This Mean for You?

Oct 29/Lauren Gelman/ PCSK9i

You may have heard that Amgen, which manufactures the cholesterol-lowering drug evolocumab (Repatha), just announced it is lowering the list price of the drug by about 60 percent to $5,850 per year from its original list price of $14,523. The company says that the goal of the price drop is to help lower patients’ copays, […]

READ MORE

New York Proclaims June as Migraine and Headache Awareness Month

Jun 05/50SN Staff/ Migraine

New York State Proclaims June as Migraine Awareness Month.

READ MORE

New Migraine Drug Approved. But Will Our Insurance Cover it?

May 18/50SN Staff/ Migraine

The U.S. Food and Drug Administration announced the approval of a new preventive migraine treatment.

READ MORE

Rheumatoid Arthritis Activism Produces Resilience and Other Rewards

Mar 30/50SN Staff/ Advocacy Testimony

Advocating for collective health issues may help you pursue your own care, fuel well-being, and more. https://www.everydayhealth.com/rheumatoid-arthritis/living-with/rheumatoid-arthritis-activism-produces-resilience/

READ MORE